A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve

Journal of the American College of Cardiology

Volumn 68, Issue 21, 2016, Pages 2247-2255

  Barbato, Emanuele ^a,b   Toth, Gabor G ^c   Johnson, Nils P ^d   Pijls, Nico H J ^e   Fearon, William F ^f   Tonino, Pim A L ^e   Curzen, Nick ^g   Piroth, Zsolt ^h   Rioufol, Gilles ⁱ   Jüni, Peter ^j,k   De Bruyne, Bernard ^a  

^a OLV HOSPITAL   (Belgium)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Department of Cardiology   (Austria)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e CATHARINA HOSPITAL   (Netherlands)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h Hungarian Institute of Cardiology   (Hungary)

ⁱ INSERM   (France)

^j ST MICHAEL'S HOSPITAL   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

clinical outcome; fractional flow reserve; stable angina; vessel related

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRACTIONAL FLOW RESERVE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; PROCEDURES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84997784985     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.08.055     Document Type: Article

References (22)

1. 1 Stone, G.W., Maehara, A., Lansky, A.J., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364 (2011), 226–235.
2. 2 Pijls, N.H., van Son, J.A., Kirkeeide, R.L., De Bruyne, B., Gould, K.L., Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87 (1993), 1354–1367.
3. 3 De Bruyne, B., Baudhuin, T., Melin, J.A., et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 89 (1994), 1013–1022.
4. 4 Pijls, N.H., De Bruyne, B., Peels, K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996), 1703–1708.
5. 5 Zimmermann, F.M., Ferrara, A., Johnson, N.P., et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 36 (2015), 3182–3188.
6. 6 Tonino, P.A., De Bruyne, B., Pijls, N.H., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 (2009), 213–224.
7. 7 De Bruyne, B., Pijls, N.H., Kalesan, B., et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367 (2012), 991–1001.
8. 8 De Bruyne, B., Fearon, W.F., Pijls, N.H., et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371 (2014), 1208–1217.
9. 9 Johnson, N.P., Tóth, G.G., Lai, D., et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 64 (2014), 1641–1654.
10. 10 Metz, L.D., Beattie, M., Hom, R., Redberg, R.F., Grady, D., Fleischmann, K.E., The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 49 (2007), 227–237.
11. 11 Shaw, L.J., Iskandrian, A.E., Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11 (2004), 171–185.
12. 12 Shaw, L.J., Berman, D.S., Maron, D.J., et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117 (2008), 1283–1291.
13. 13 Hachamovitch, R., Hayes, S.W., Friedman, J.D., Cohen, I., Berman, D.S., Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003), 2900–2907.
14. 14 Hachamovitch, R., Rozanski, A.R., Hayes, S.W., et al. Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both left ventricular ejection fraction and stress-induced myocardial ischemia necessary?. J Nucl Cardiol 13 (2006), 768–778.
15. 15 Hachamovitch, R., Rozanski, A., Shaw, L.J., et al. Impact of ischemia and scar on therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 32 (2011), 1012–1024.
16. 16 Erne, P., Schoenenberger, A.W., Burckhardt, D., et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 297 (2007), 1985–1991.
17. 17 Hamilos, M., Muller, O., Cuisset, T., et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 120 (2009), 1505–1512.
18. 18 Muller, O., Mangiacapra, F., Ntalianis, A., et al. Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol Intv 4 (2011), 1175–1182.
19. 19 Puymirat, E., Peace, A., Mangiacapra, F., et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease. Circ Cardiovasc Interv 5 (2012), 62–68.
20. 20 Toth, G., De Bruyne, B., Casselman, F., et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation 128 (2013), 1405–1411.
21. 21 Adjedj, J., De Bruyne, B., Floré, V., et al. Significance of intermediate values of fractional flow reserve in patients with coronary artery disease. Circulation 133 (2016), 502–508.
22. 22 Depta, J.P., Patel, J.S., Novak, E., et al. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment. Eur Heart J 36 (2015), 509–515.